Home > Financial Ratios > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results

JUBILANT PHARMOVA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 26.9219.03-30.24-17.43-10.80

What is the latest Core EBITDA Growth ratio of JUBILANT PHARMOVA ?

The latest Core EBITDA Growth ratio of JUBILANT PHARMOVA is 26.92 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202526.92
Mar202419.03
Mar2023-30.24
Mar2022-17.43
Mar2021-10.80

How is Core EBITDA Growth of JUBILANT PHARMOVA Trending?

Years Core EBITDA Growth % Change
Mar2025 26.92
41.46
Mar2024 19.03
Positive
Mar2023 -30.24
Negative
Mar2022 -17.43
Negative
Mar2021 -10.8 -

Other Financial Ratios of JUBILANT PHARMOVA


Compare Core EBITDA Growth ratio of peers of JUBILANT PHARMOVA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JUBILANT PHARMOVA ₹17,644.9 Cr -4.6% -3.6% 30% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹383,570.0 Cr -1.9% -4.1% -6.6% Stock Analytics
DIVIS LABORATORIES ₹162,808.0 Cr -3.6% -12.3% 27.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,734.0 Cr -2.1% 7.2% 9.3% Stock Analytics
CIPLA ₹120,468.0 Cr -0.7% -0% -2.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,212.0 Cr -1.6% -5.4% -12.1% Stock Analytics


JUBILANT PHARMOVA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JUBILANT PHARMOVA

-4.6%

-3.6%

30%

SENSEX

-0.7%

-3.7%

2.4%


You may also like the below Video Courses